title: Early behavior of biochemical markers in patients with thrombolysis in myocardial infarction grade 2 flow in the infarct artery as opposed to other flow grades after intravenous thrombolysis for acute myocardial infarction. PERM Study Group. Prospective Evaluation of Reperfusion Markers.
abstract: BACKGROUND
  Biochemical markers have been suggested for the noninvasive diagnosis of reperfusion early after thrombolysis. Their ability to discriminate between Thrombolysis in Myocardial Infarction (TIMI) 2 and 3 flow grades remains unknown.
  
  
  METHODS
  In 97 patients with myocardial infarction < or =6 hours, myoglobin, troponin T, MBCK, and MMCK isoforms were measured before thrombolysis and after 90 minutes. A 90-minute coronary angiography ascertained the potency status of the infarct-related artery in all patients according to the TIMI grade flow (group A: TIMI 0-1 (n = 35), group B: TIMI 2 (n = 17), and group C: TIMI 3 (n = 45). For each marker the absolute rate of increase and the relative increase 90 minutes after thrombolysis were studied.
  
  
  RESULTS
  Both absolute values and absolute rates of increase at 90 minutes of myoglobin were higher in group B than in groups A and C (p < 0.05, not significant for other markers). Relative increases were consistently higher in group C than in other groups with statistical significance for myoglobin in the subset of patients treated for >3 hours.
  
  
  CONCLUSIONS
  Diagnostic indexes based on relative increases tend to discriminate between patients with TIMI 2 and 3 flow, and the best performance is obtained when the relative increase of myoglobin at 90 minutes is used in patients treated later than 3 hours after onset of symptoms.
authors.affiliation: Cardiology Department of Hôpital Beaujon, Clichy, France.
authors.forename: T
authors.initials: T
authors.lastname: Laperche
authors.forename: J L
authors.initials: JL
authors.lastname: Golmard
authors.forename: P G
authors.initials: PG
authors.lastname: Steg
mesh_terms: D000368:Aged; D015415:Biomarkers / Q000097:blood*; D003331:Coronary Vessels / Q000473:pathology; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000097:blood / Q000188:drug therapy* / Q000503:physiopathology*; D009211:Myoglobin / Q000097:blood; D012189:Retrospective Studies; D012720:Severity of Illness Index; D015912:Thrombolytic Therapy; D013997:Time Factors; D014654:Vascular Patency
chemical_list: D015415:Biomarkers; D009211:Myoglobin